FRANKFURT (Reuters) – COVID-19 vaccine maker Biontech said on Tuesday that it and partner Pfizer have filed a complaint with the U.S. District Court in Massachusetts, seeking a judgment that they did not infringe U.S. patents held by rival CureVac.
CureVac earlier this month filed a patent lawsuit in Germany against BioNTech over its use of mRNA technology and did not rule out further legal action against BioNTech’s partner Pfizer or rival mRNA vaccine maker Moderna.
(Reporting by Ludwig Burger, editing by Kirsti Knolle)
